OpenVSafe by OpenVAERS
Search V-safe

BSS-17911-16426

3 vaccinations 3 coded responses 10 check-ins 3 free-text entries 1 call case
Sex
Female
Age at first dose
61-65
ZIP prefix
070 / NJ
Registered
2021-01-27
Relationship
Self
Race
Asian
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-12
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-12
    Dose 2 — Pfizer-BioNTech
  3. 2021-01-27
    Registered in v-safe
  4. 2021-01-27
    Survey response — day 14, dose 1
    MedDRA: Haemorrhage, Skin lesion, Specialist consultation — Feeling: Good · Get care from a doctor or other healthcare professional
    Free text: Symptoms: Eight hours after recieving the second dose, I developed small non-raised pinpoint lesions over the anterior aspect of my legs. The pinpoint lesions started to spread overnight into 5 inch by 5 inch flat, non-raised lesions that became hemorrhagic. · Healthcare visit (other): Dermatologist, in office.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-01-27
    Report sent to call center — day 14, dose 1
    Get care from a doctor or other healthcare professional
    1 call case(s)
  6. 2021-02-02
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  7. 2021-02-09
    Survey response — day 28, dose 2
    MedDRA: Injection site rash, Rash — Feeling: Good
    Free text: Rash similar to the initial on legs on injection side upper arm only. Occurred around 1/30. Incorrectly submitted last weeks check in.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-02-16
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  9. 2021-02-23
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  10. 2021-04-14
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  11. 2021-04-14
  12. 2021-07-15
    Survey response — 6 months, dose 2
    MedDRA: Rash — Feeling: Good
    Free text: Same time of rash on the right inner thigh.
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  13. 2022-01-19
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in
  14. 2022-01-31
    Dose 3 — Pfizer-BioNTech
  15. 2022-05-04
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  16. 2023-01-31
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-12Pfizer-BioNTech
22021-01-12Pfizer-BioNTech
32022-01-31Pfizer-BioNTech No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 2 — day 14, dose 1

2021-01-27

Symptoms: Eight hours after recieving the second dose, I developed small non-raised pinpoint lesions over the anterior aspect of my legs. The pinpoint lesions started to spread overnight into 5 inch by 5 inch flat, non-raised lesions that became hemorrhagic. cut off by CDC
Healthcare visit (other): Dermatologist, in office.

Release 3 — day 28, dose 2

2021-02-09

Symptoms: Rash similar to the initial on legs on injection side upper arm only. Occurred around 1/30. Incorrectly submitted last weeks check in.

Release 9 — 6 months, dose 2

2021-07-15

Symptoms: Same time of rash on the right inner thigh.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOSpecialist consultation ✓ ✓ ✓
SDHaemorrhage ✓ ✓ ✓
SDInjection site rash ✓ ✓ ✓
SDRash ✓ ✓ ✓
SDSkin lesion ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release